Director, portfolio manager, UK Life Sciences, UBS
Drew is the portfolio manager for the UK life sciences strategy and is the lead investment manager across the vehicle. She was previously a transactions manager for Real Estate UK (RE-UK), a business which forms part of Real Estate & Private Markets (REPM) business within UBS Asset Management (UBS-AM). Drew also had responsibilities across the REPM business on ESG strategies, supporting the growth of the sustainable product shelf and integrating ESG policies across the platform. She joined UBS-AM in December 2017 as a member of the RE-UK team, providing support to several funds and segregated mandates within the UK platform. Prior to joining UBS-AM, she worked a t M&G Investments (2014-2017), first as a graduate trainee, and then as an analyst specialising in long lease property funds. She is a CFA charterholder, and also holds the Investment Management Certificate.